Medicrea International SA announced sales results for the year 2012. For the year, the company has reported sales of EUR 20.7 million, up 8.5% from EUR 19.1 million reported in 2011. This performance was achieved within a global competitive and economic environment that has become tougher over the last 2 years because of pressure from reimbursement systems in Europe and the United States.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -0.58% | +134.69% |
1st Jan change | Capi. | |
---|---|---|
+134.69% | 182M | |
+13.62% | 130B | |
-9.08% | 10.81B | |
-18.14% | 7.12B | |
+48.89% | 6.46B | |
-34.21% | 3.98B | |
+8.03% | 3.43B | |
-19.31% | 2.48B | |
-18.50% | 1.91B | |
-24.94% | 1.66B |
- Stock Market
- Equities
- ALMED Stock
- News Medicrea International
- Medicrea International SA Announces Sales Results for the Year 2012